Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ¥5.72B | ¥5.81B | ¥4.90B | ¥3.43B | ¥4.48B | ¥3.96B | ¥8.62B | ¥11.24B | ¥11.53B | ¥3.24B | ¥1.31B | ¥196.5M |
| Research & development | ¥406.6M | ¥411.9M | ¥148.8M | ¥151.9M | ¥208.0M | — | — | — | — | — | — | — |
| Operating income | −¥5.94B | −¥4.16B | −¥2.30B | ¥1.62B | — | — | — | — | — | — | — | — |
| EBITDAderived | −¥5.93B | −¥4.15B | −¥2.29B | ¥1.65B | — | — | — | — | — | — | — | — |
| Net income | ¥54.5M | ¥1.58B | ¥2.08B | ¥1.19B | ¥1.03B | −¥692.7M | ¥1.16B | ¥1.58B | −¥188.1M | ¥1.12B | ¥275.3M | −¥27.7M |
| Basic EPSper diluted share | CN¥0.31 | CN¥9.13 | CN¥11.77 | CN¥6.84 | CN¥6.11 | -CN¥3.84 | CN¥6.24 | CN¥8.58 | -CN¥1.03 | CN¥9.44 | CN¥2.74 | -CN¥0.28 |
| Diluted EPSper diluted share | CN¥0.31 | CN¥9.06 | CN¥11.64 | CN¥6.81 | CN¥6.06 | -CN¥3.84 | CN¥6.20 | CN¥8.48 | -CN¥1.03 | CN¥9.39 | CN¥2.74 | -CN¥0.28 |